USCI JAPAN INVESTS IN ANGIOSCORE

AngioScore Inc. has landed a $1.5 million equity investment from USCI Japan Ltd., the company announced Thursday. In a separate agreement, the two signed a distribution deal that gives USCI exclusive rights to sell AngioScore's balloon catheter in Japan for all coronary treatments. Under terms of the distribution deal, USCI Japan will be responsible all registration activities for the Alameda company's AngioSculpt product in Japan. The medical device distributor will launch AngioSculpt once the product receives regulatory approvals.

East Bay Business Times (http://eastbay.bizjournals.com/eastbay/stories/2005/08/22/daily28.html)